Information sur le laboratoire
Todd Lee (M.D.)
ScientifiqueUnité de recherche clinique
Département de médecine (McGill)
Profil de recherche
https://www.drtoddlee.com/
Mots-clés
Amélioration de la qualité • gestion de l'utilisation des antimicrobiens • résistance aux antibiotiques • essaies cliniques • polypharmacieIntérêts de recherche
Mes recherches portent sur la réalisation d'essais cliniques randomisés visant à améliorer le traitement des maladies infectieuses (par exemple, C. difficile, COVID-19, S. aureus, infections à Gram négatif) et à innover dans les domaines des soins de patients hospitalisés complexes, des soins des adultes plus âgés atteints de polypharmacie, et de la gérance des ressources en soins de santé (par exemple, les tests et les médicaments).Membre de l'équipe
| Nom | Poste |
|---|
Dernières publications
- Spellberg, B., Ghanem, B., Russell, C. D., So, M., Kang, M., Forrest, G., Cabanilla, M. G., Donovan, R., Whitehouse, M., Yen, C., Tong, S. Y. C., Ahn, J., Minejima, E., Davar, K., Tucker, C., Footer, B., Lee, R., Wald-Dickler, N., McDonald, M. E. G., Lee, T. C. & WikiGuidelines Group (2025). 2025 Update to WikiGuidelines for the Management of Pyogenic Osteomyelitis in Adults. The American journal of medicine.
- Prosty, C., Lee, T. C. & McDonald, E. G. (2025). Antibiotic Prophylaxis in Patients With Cirrhosis Presenting With Variceal Bleeding-Are We Treating the Past?-Reply. JAMA internal medicine.
- Lee, J. J., Filosa, E., Pierson, T., Khuong, N., Gagnon, C., Herbin, J., Rej, S., Godard-Sebillotte, C., Tamblyn, R., Lee, T. C. & McDonald, E. G. (2025). Assessing the acceptability and usability of MedSafer, a patient-centered electronic deprescribing tool. JAMIA open, vol. 8, p. ooaf141.
- Spellberg, B., Wald-Dickler, N., Holtom, P., Meyer-Sautter, P., Camp, A., Diaz, A. D., Buhamad, R., Vazquez, A. S. M., Aguirre-Garcia, G. M., Stanton, M., Butler-Wu, S. M., Chiu, I., Ergenc, Z., Bhoojhawon, G., Murri, R., Maraolo, A. E., Cabanilla, G., Riccardi, N., Tshisevhe, V., Behenna, C., Williams, K. S., Kufel, W. D., Wojciaczyk, N., Pimentel, B. V., Muyidi, A., Costa, R. P. L., Motta, F., Bortolussi-Courval, É., Lee, T. C., McDonald, E. G., Ghanem, B. & Nelson, Z. (2025). Reply to Datta, "Is static or cidal antibiotic falsifiable?". Antimicrobial agents and chemotherapy, p. e0139125.
- Deas, G., Lee, T. C., Colston, J., Albur, M., Vasant, J., Nobbs, A. H., Williams, P. & Hamilton, F. (2025). Streptococcal endocarditis: a meta-analysis of species dependant risk. EClinicalMedicine, vol. 87, p. 103425.
- Mellett, M., Van Riel, J., Corsini, R., Satola, S., Lawandi, A., Caya, C., van Hal, S., Lee, T. C., Papenburg, J., Yansouni, C. P., Babiker, A. & Cheng, M. P. (2025). The combinations of cefazolin with linezolid and cefazolin with clindamycin are indifferent against methicillin-susceptible Staphylococcus aureus. Microbiology spectrum, p. e0176325.
- Aw, M., Lee, T. C., Mendel, A. & Colmegna, I. (2025). Parvovirus B19-Associated Large-Vessel Vasculitis in an Immunocompromised Patient. The Journal of rheumatology.
- Turner, N. A., Hamasaki, T., Doernberg, S. B., Lodise, T. P., King, H. A., Ghazaryan, V., Cosgrove, S. E., Jenkins, T. C., Liu, C., Sharma, S., Zaharoff, S., Wahid, L., Renard, V. J., Cook, P., Raad, I., Hachem, R., Chaftari, A.-M., Sims, M., DeMarco, C., Miller, L. G., McCarthy, M. W., Morse, C. G., Lucasti, C., Forrest, G. N., Cherabuddi, K., Polk, C., Fazili, T., Rupp, M. E., Thompson, G. R., Kim, K., Strnad, L., Schnee, A. E., McKinnell, J. A., Ramesh, M., Silveira, F. P., McCarty, T. P., Lee, T. C., McDonald, E. G., Paolino, K., Wiegand, K., Wall, A., Riccobene, T., Patel, R., Rappo, U., Evans, S., Chambers, H. F., Fowler, V. G., Holland, T. L. & Antibacterial Resistance Leadership Group (2025). Dalbavancin for Treatment of Staphylococcus aureus Bacteremia: The DOTS Randomized Clinical Trial. JAMA.
- Prosty, C., Noutsios, D., Dubé, L.-R., Baden, R., Davar, K., Freling, S., Bhuket, T., Yee, H. F., Spellberg, B., McDonald, E. G. & Lee, T. C. (2025). Prophylactic Antibiotics for Upper Gastrointestinal Bleeding in Patients With Cirrhosis: A Systematic Review and Bayesian Meta-Analysis. JAMA internal medicine, vol. 185, p. 1194-1203.
- Hosseini, B., Condon, A., da Costa, B. R., Daley, P., Greiver, M., Jüni, P., Lee, T. C., McBrien, K., McDonald, E. G., Murthy, S., Selby, P., Andrew, M., Aubrey-Bassler, K., Barber, D., Barrett, B., Butler, C. C., Crampton, N., Dahrouge, S., Damji, A., Fowler, R., Garies, S., Hudon, C., Hulme, J., Isenor, J., Jenkins, D. J. A., Lall, R., LeBlanc, A., Leong, C., Little, P., Lofters, A., Logsetty, S., Lother, S., Lussier, M.-T., Maclaren, L., Mangin, D., Marshall, E. G., Marshall, J. C., McCracken, R., Moineddin, R., Orava, B., Paquette, J.-S., Park, J. J. H., Persaud, N., Rac, V. E., Ramsden, V. R., Rayner, J., Sanchez-Ramirez, D. C., Saxinger, L., Shi, H., Singer, A., Spiwak, R., Srivastava, A., Sud, A., Tarride, J.-E., Telner, D., Upshur, R. E. G., Walji, S., Walsh, R., Wilchesky, M., Wong, S. T., Wood, B., Zarychanski, R., Zelek, B., Keynan, Y., Piszczek, J., Warshafsky, D. & Pinto, A. D. (2025). Canadian Adaptive Platform Trial of Treatments for COVID in Community Settings (CanTreatCOVID): protocol for a randomised controlled adaptive platform trial of treatments for acute SARS-CoV-2 infection in community settings. BMJ open, vol. 15, p. e097134.
Voir aussi
